Cambridge Investment Research Advisors, Inc. - REDHILL BIOPHARMA LTD ownership

Back to all holdings Add to watchlist

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 50 filers reported holding REDHILL BIOPHARMA LTD in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q1 2022$65,000
-8.5%
25,632
-7.2%
0.00%–
Q4 2021$71,000–27,632–0.00%–
 Download
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q2 2022
NameSharesValueWeighting ↓
IFP Advisors, Inc 300$2,1750.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REDHILL BIOPHARMA LTD shareholders